Alpha 2.0
Login Register
» Articles » PMID: 10222421

Paraneoplastic Opsoclonus-myoclonus Secondary to Malignant Melanoma

Overview
Journal J Neurooncol
Publisher Springer
Date 1999 May 1
PMID 10222421
Citations 8
Authors
J R Berger
E Mehari
Affiliations
Soon will be listed here.
Abstract

Opsoclonus-myoclonus is a well-described paraneoplastic syndrome that most often occurs in association with small cell carcinoma of the lung and breast carcinoma. To the best of our knowledge, we describe the first reported case of paraneoplastic opsoclonus-myoclonus occurring is association with malignant melanoma. Antineuronal antibodies were not identified despite repeated testing. No therapeutic benefit was observed following corticosteroid administration.

Citing Articles

Paraneoplastic syndromes in patients with melanoma.

Dec M, Arasiewicz H Postepy Dermatol Alergol. 2024; 41(3):251-261.

PMID: 39027696 PMC: 11253314. DOI: 10.5114/ada.2024.141114.

Detection of High-Risk Paraneoplastic Antibodies against TRIM9 and TRIM67 Proteins.

Bartley C, Ngo T, Do L, Zekeridou A, Dandekar R, Muniz-Castrillo S Ann Neurol. 2023; 94(6):1086-1101.

PMID: 37632288 PMC: 10842626. DOI: 10.1002/ana.26776.

Paraneoplastic opsoclonus-myoclonus syndrome secondary to melanoma metastasis form occult primary cancer.

Mondragon J, Jimenez-Zarazua O, Velez-Ramirez L, Martinez-Rivera M, Enriquez-Maciel S, Gonzalez-Guzman J Case Rep Neurol. 2019; 11(1):66-79.

PMID: 31543788 PMC: 6739717. DOI: 10.1159/000497034.

Adult-onset opsoclonus-myoclonus-ataxia syndrome as a manifestation of brazilian lyme disease-like syndrome: a case report and review of literature.

Lino A, Spera R, de Campos F, Freitas C, Garcia M, da Costa Lopes L Autops Case Rep. 2017; 4(1):29-37.

PMID: 28652990 PMC: 5470562. DOI: 10.4322/acr.2014.005.

"Dancing eye syndrome" secondary to opsoclonus-myoclonus syndrome in small-cell lung cancer.

Laroumagne S, Elharrar X, Coiffard B, Plojoux J, Dutau H, Breen D Case Rep Med. 2014; 2014:545490.

PMID: 24778658 PMC: 3981168. DOI: 10.1155/2014/545490.

References
1.
Pranzatelli M . The neurobiology of the opsoclonus-myoclonus syndrome. Clin Neuropharmacol. 1992; 15(3):186-228. DOI: 10.1097/00002826-199206000-00002. View
2.
Cher L, Hochberg F, Teruya J, Nitschke M, Valenzuela R, Schmahmann J . Therapy for paraneoplastic neurologic syndromes in six patients with protein A column immunoadsorption. Cancer. 1995; 75(7):1678-83. DOI: 10.1002/1097-0142(19950401)75:7<1678::aid-cncr2820750719>3.0.co;2-2. View
3.
Luque F, Furneaux H, Ferziger R, Rosenblum M, Wray S, Schold Jr S . Anti-Ri: an antibody associated with paraneoplastic opsoclonus and breast cancer. Ann Neurol. 1991; 29(3):241-51. DOI: 10.1002/ana.410290303. View
4.
Solomon G, CHUTORIAN A . Opsoclonus and occult neuroblastoma. N Engl J Med. 1968; 279(9):475-7. DOI: 10.1056/NEJM196808292790907. View
5.
Sais G, Marcoval J, Juggla A, Curco N, Servitje O . Dermatomyositis and metastatic malignant melanoma, with complete regression of the primary lesion. Br J Dermatol. 1994; 130(6):796-7. DOI: 10.1111/j.1365-2133.1994.tb03424.x. View